Browsing Tag
NASDAQ
287 posts
Fermi (Nasdaq & LSE: FRMI) scales Project Matador with Hyundai Engineering & Construction and MUFG backing
Fermi Inc. (FRMI) advances Project Matador with Hyundai Engineering & Construction and MUFG backing. Explore what this means for US nuclear and AI power demand.
Is Blue Moon Metals (NASDAQ: BMM) building the rare US tungsten processing hub Washington has been asking for?
Blue Moon Metals closes its Springer tungsten mine acquisition in Nevada as Section 232 boosts US supply chain focus. Discover what it means next.
NeuroSense Therapeutics (NASDAQ: NRSN) extends PrimeC exclusivity to 2042 with Australian patent as Phase 3 focus intensifies
Find out how NeuroSense Therapeutics’ Australian patent grant strengthens PrimeC’s long-term outlook as the ALS program advances toward Phase 3.
Addentax (NASDAQ: ATXG) targets offshore wealth and digital assets in proposed Hong Kong fintech acquisition
Find out how Addentax Group Corp. plans to pivot into AI-driven, crypto-enabled wealth management through a Hong Kong acquisition targeting HKD 300 million revenue.
Axcelis Technologies, Veeco Instruments move closer to $4.4bn semiconductor equipment combination
Axcelis Technologies shareholders approve the Veeco Instruments merger. Find out what changes now, what risks remain, and what it means for investors.
Brand Engagement Network exits $50m equity line to reset dilution profile and capital discipline (NASDAQ: BNAI)
Brand Engagement Network has terminated a $50M equity line to cut dilution risk. Find out how this move could reshape investor sentiment and AI execution.
VHUB listing: VenHub Global Inc’s Nasdaq entry bets on autonomous retail format and smart infrastructure
Discover how VenHub Global Inc’s Nasdaq direct listing under VHUB advances autonomous retail infrastructure and what this means for investors and industry.
Can Galmed Pharmaceuticals avoid delisting? Nasdaq compliance clock is ticking
Nasdaq has notified Galmed Pharmaceuticals of a share price deficiency. Find out what this means for investors and the company's future strategy.
What’s going on at Olema Oncology? CFO + COO Hans Bishop exits suddenly
Olema Oncology CFO and COO Hans Bishop has stepped down ahead of OP-1250 trial milestones. Find out what this means for investors and pipeline strategy.
How Austria’s Wolfsberg renewal strengthens Critical Metals Corp’s timing leverage in a tightening lithium market (NASDAQ: CRML)
Austria extends Wolfsberg’s license, giving Critical Metals Corp time to align lithium development with market recovery. Find out why this timing matters now.